Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.22)
# 3,748
Out of 5,152 analysts
58
Total ratings
40.54%
Success rate
-7.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $184 → $157 | $169.94 | -7.61% | 6 | Feb 10, 2026 | |
| PODD Insulet | Maintains: Overweight | $350 → $360 | $240.94 | +49.41% | 6 | Nov 7, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $142 → $146 | $111.04 | +31.48% | 9 | Oct 16, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $13.60 | +47.06% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $22.63 | +262.35% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $117.57 | +110.94% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $496.70 | -31.75% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.71 | +111.27% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $1.61 | +1,577.02% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $93.45 | +18.78% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $70.69 | +103.35% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $112.10 | -50.04% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $73.49 | +0.69% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $83.89 | -8.61% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $14.23 | +532.47% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $89.29 | - | 1 | Dec 12, 2019 |
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Equal-Weight
Price Target: $184 → $157
Current: $169.94
Upside: -7.61%
Insulet
Nov 7, 2025
Maintains: Overweight
Price Target: $350 → $360
Current: $240.94
Upside: +49.41%
Abbott Laboratories
Oct 16, 2025
Maintains: Overweight
Price Target: $142 → $146
Current: $111.04
Upside: +31.48%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $13.60
Upside: +47.06%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $22.63
Upside: +262.35%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $117.57
Upside: +110.94%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $496.70
Upside: -31.75%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.71
Upside: +111.27%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $1.61
Upside: +1,577.02%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $93.45
Upside: +18.78%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $70.69
Upside: +103.35%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $112.10
Upside: -50.04%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $73.49
Upside: +0.69%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $83.89
Upside: -8.61%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $14.23
Upside: +532.47%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $89.29
Upside: -